NEW YORK (GenomeWeb News) – Ending months of speculation, CuraGen said publicly last week it has begun looking for strategic options for its majority stake in 454 Life Sciences.
 
The company cited as reasons the desire to “ensure funding for our advanced oncology pipeline and ensure that 454 Life Sciences has sufficient resources to support its growth and expansion.”
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.